Protocol HNS 94-001 
October 4, 1994 
Page 14 
Assoc Cancer Res 1990;31:304. 
i 
12. Soriano P, Montgomery C, Geske R, Bradley A. Targeted disruption of the c-src proto-oncogene leads to 
osteopetrosis in mice. Cell 1991;64:693-702. 
13. Chen P-L, Chen Y, Bookstein R, Lee W-H. Genetic mechanisms of tumor suppression by the human p53 
gene. Science 1990;250:1576-1580. 
14. Yonish-Rouach E, Resnitzky D, Rotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of 
myeloid leukemic cells that is inhibited by interleukin-6. Nature 1991;352:345-347. 
15. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J. Induction of apoptosis by wild-type p53 in a human 
colon tumor-derived cell line. Proc Natl Acad Sci USA 1992;4495:4499. 
1 6. Fujiwara T, Grimm EA, Mukhopadhyay T, Cai DW, Owen-Schaub LB, Roth JA. A retroviral wild-type p53 
expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. 
Cancer Res 1993;53:4129-4133. 
17. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of 
anticancer agents. Cell 1993;74:957-967. 
18. Merino OR, Lindberg RD, Fletcher GH. An analysis of distant metastasis from squamous cell carcinoma of the 
upper respiratory and digestive tracts. Cancer 1977; 40: 147-156. 
19. Votova C Jr, Fletcher GH, Jesse RH Jr, Lindberg RD. Management of cervical nodes, either fixed or bilateral, 
from squamous cell carcinoma of the oral cavity and faucial arch. Radiology 1972; 105: 417-420. 
20. Komaki R, Garden AS, Cundiff JH. Endobronchial Radiotherapy. In: Roth JA, Hong WK, Cox JD, eds. 
Advances in Lung Cancer. Cambridge, MA: Blackwell Scientific Publications, Inc., 1992: 
21 . Boshart M, Weber F, Jahn G, Dorsch-Hasler K, Fleckenstein B, Schaffner W. A very strong enhancer is 
located upstream of an immediate early gene of human cytomegalovirus. Cell 1985;41 :521-530. 
22. Mcgrory WJ, Bautista DS, Graham FL. A simple technique for the rescue of early region I mutations into 
infectious human adenovirus type 5. Virology 1988;163:614-617. 
23. Graham FL, Eb VD. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 
1973;52:456-467. 
24. Zhang WW, Fang X, Branch CD, Mazur W, French BA, Roth JA. Generation and identification of recombinant 
adenovirus by lipsome-mediated transfection and PCR analysis. BioTechniques 1993; 
25. Graham FL, Prevec L. Manipulation of adenovirus vectors. In: Murray EJ, ed. Methods in Molecular Biology, 
Gene Transfer and Expression Protocols. New Jersey: The Humana Press Inc, 1991 :109-128. 
26. Dai Y, Roman M, Naviaux RK, Verma IM. Gene therapy via primary myoblasts: long-term expression of factor IX 
protein following transplantion in vivo. Proc Natl Acad Sci USA 1993;89:10892-10895. 
27. Georges RN, Mukhopadhyay T, Zhang YJ, Yen N, Roth JA. Prevention of orthotopic human lung cancer 
growth by intratracheal instillation of a retroviral antisense K-ras contruct. Cancer Res 1993;53:1743-1746. 
28. Casson AG, Mukhopadhyay T, Cleary KR, Ro JY, Levin B, Roth JA. p53 gene mutations in Barrett's 
epithelium and esophageal cancer. Cancer Res 1991;51:4495-4499. 
29. Ajani JA, Welch SR, Raber MN, Fields WS, Krakoff IH. Comprehensive criteria for assessing therapy-induced 
toxicity. Cancer Invest 1990;8 (2) :1 47-1 59. 
Recombinant DNA Research, Volume 20 
[ 659 ] 
